Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms. Article

Overview

authors

Motzer, Robert John
Johnson, T
Choueiri, T K
Deen, K C
Xue, Z
Pandite, L N
Carpenter, C
Xu, C F

publication date

October 9, 2013

published in

Annals of oncology : official journal of the European Society for Medical Oncology Journal

Research

keywords

Glucuronosyltransferase
Hyperbilirubinemia
Indoles
Pyrimidines
Pyrroles
Sulfonamides

Identity

PubMed Central ID

PMC6394110

Scopus Document Identifier

84887070467

Digital Object Identifier (DOI)

10.1093/annonc/mdt394

PubMed ID

24107802

Additional Document Info

has global citation frequency

28

volume

24

issue

11